2023 Q2 Form 10-Q Financial Statement
#000165495423005861 Filed on May 05, 2023
Income Statement
Concept | 2023 Q2 | 2023 Q1 |
---|---|---|
Revenue | $0.00 | $0.00 |
YoY Change | ||
Cost Of Revenue | ||
YoY Change | ||
Gross Profit | ||
YoY Change | ||
Gross Profit Margin | ||
Selling, General & Admin | $315.0K | $476.0K |
YoY Change | 13.72% | 23.0% |
% of Gross Profit | ||
Research & Development | $555.0K | $275.0K |
YoY Change | -41.64% | 21.68% |
% of Gross Profit | ||
Depreciation & Amortization | $6.000K | $6.000K |
YoY Change | -25.0% | -25.0% |
% of Gross Profit | ||
Operating Expenses | $876.0K | $757.0K |
YoY Change | -29.13% | 21.9% |
Operating Profit | ||
YoY Change | ||
Interest Expense | -$164.0K | $377.0K |
YoY Change | -59.8% | 138.61% |
% of Operating Profit | ||
Other Income/Expense, Net | -$164.0K | $377.0K |
YoY Change | -63.96% | 252.34% |
Pretax Income | -$1.040M | -$380.0K |
YoY Change | -38.5% | -26.07% |
Income Tax | ||
% Of Pretax Income | ||
Net Earnings | -$1.040M | -$380.0K |
YoY Change | -38.5% | -26.07% |
Net Earnings / Revenue | ||
Basic Earnings Per Share | ||
Diluted Earnings Per Share | -$0.02 | -$0.01 |
COMMON SHARES | ||
Basic Shares Outstanding | 64.80M shares | 64.80M shares |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2023 Q2 | 2023 Q1 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $3.624M | $4.881M |
YoY Change | 944.56% | 177.65% |
Cash & Equivalents | $496.0K | $440.0K |
Short-Term Investments | $3.128M | $4.441M |
Other Short-Term Assets | $366.0K | $26.00K |
YoY Change | 351.85% | -91.8% |
Inventory | ||
Prepaid Expenses | ||
Receivables | ||
Other Receivables | ||
Total Short-Term Assets | $3.990M | $4.907M |
YoY Change | -44.87% | -43.53% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $16.84M | $16.76M |
YoY Change | 2.21% | 1.91% |
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | ||
YoY Change | ||
Other Assets | $4.000K | $4.000K |
YoY Change | -97.58% | -33.33% |
Total Long-Term Assets | $16.85M | $16.76M |
YoY Change | 2.21% | 1.9% |
TOTAL ASSETS | ||
Total Short-Term Assets | $3.990M | $4.907M |
Total Long-Term Assets | $16.85M | $16.76M |
Total Assets | $20.84M | $21.67M |
YoY Change | -12.16% | -13.8% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $235.0K | $188.0K |
YoY Change | -52.04% | -18.26% |
Accrued Expenses | $31.00K | $25.00K |
YoY Change | -26.19% | -32.43% |
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Long-Term Debt Due | ||
YoY Change | ||
Total Short-Term Liabilities | $274.0K | $213.0K |
YoY Change | -48.5% | -20.22% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Other Long-Term Liabilities | $195.0K | $125.0K |
YoY Change | 40.29% | -16.67% |
Total Long-Term Liabilities | $195.0K | $125.0K |
YoY Change | 40.29% | -16.67% |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $274.0K | $213.0K |
Total Long-Term Liabilities | $195.0K | $125.0K |
Total Liabilities | $469.0K | $338.0K |
YoY Change | -30.1% | -18.94% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$55.31M | -$54.27M |
YoY Change | 6.03% | |
Common Stock | $649.0K | $648.0K |
YoY Change | 0.15% | |
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | $20.37M | $21.33M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $20.84M | $21.67M |
YoY Change | -12.16% | -13.8% |
Cashflow Statement
Concept | 2023 Q2 | 2023 Q1 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | -$1.040M | -$380.0K |
YoY Change | -38.5% | -26.07% |
Depreciation, Depletion And Amortization | $6.000K | $6.000K |
YoY Change | -25.0% | -25.0% |
Cash From Operating Activities | -$1.080M | -$685.0K |
YoY Change | 60.0% | 14.74% |
INVESTING ACTIVITIES | ||
Capital Expenditures | $9.000K | $0.00 |
YoY Change | -118.37% | -100.0% |
Acquisitions | ||
YoY Change | ||
Other Investing Activities | $1.131M | $809.0K |
YoY Change | 56.22% | -152.13% |
Cash From Investing Activities | $1.122M | $809.0K |
YoY Change | 66.22% | -151.79% |
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | 14.00K | 0.000 |
YoY Change | 1300.0% | -100.0% |
NET CHANGE | ||
Cash From Operating Activities | -1.080M | -$685.0K |
Cash From Investing Activities | 1.122M | $809.0K |
Cash From Financing Activities | 14.00K | 0.000 |
Net Change In Cash | 56.00K | $124.0K |
YoY Change | 5500.0% | -205.98% |
FREE CASH FLOW | ||
Cash From Operating Activities | -$1.080M | -$685.0K |
Capital Expenditures | $9.000K | $0.00 |
Free Cash Flow | -$1.089M | -$685.0K |
YoY Change | 73.96% | 16.7% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2023Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
757000 | usd |
CY2023Q1 | us-gaap |
Other Interest And Dividend Income
OtherInterestAndDividendIncome
|
27000 | usd |
CY2022Q1 | us-gaap |
Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
|
-51000 | usd |
CY2022Q1 | us-gaap |
Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
|
213000 | usd |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-514000 | usd |
CY2023Q1 | us-gaap |
Profit Loss
ProfitLoss
|
380000 | usd |
CY2022Q1 | us-gaap |
Profit Loss
ProfitLoss
|
514000 | usd |
CY2023Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
6000 | usd |
CY2022Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
8000 | usd |
CY2023Q1 | us-gaap |
Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
|
329000 | usd |
CY2022Q1 | us-gaap |
Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
|
213000 | usd |
CY2023Q1 | us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
67000 | usd |
CY2022Q4 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
125000 | usd |
CY2023Q1 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | usd |
CY2023Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
64801373 | shares |
CY2023Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
648000 | usd |
CY2023Q1 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
74953000 | usd |
CY2023Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-54268000 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
21333000 | usd |
CY2022Q4 | us-gaap |
Assets
Assets
|
22034000 | usd |
CY2022Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
228000 | usd |
CY2023Q1 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
25000 | usd |
CY2023Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
213000 | usd |
CY2023Q1 | us-gaap |
Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
|
125000 | usd |
CY2022Q4 | us-gaap |
Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
|
125000 | usd |
CY2023Q1 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
125000 | usd |
CY2023Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
CY2023Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
CY2023Q1 | dei |
Security Exchange Name
SecurityExchangeName
|
NYSE | |
CY2023Q1 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2023Q1 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2023Q1 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2023Q1 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2023Q1 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
CY2023Q1 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2023Q2 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
64801373 | shares |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
316000 | usd |
CY2022Q4 | us-gaap |
Short Term Investments
ShortTermInvestments
|
3951000 | usd |
CY2023Q1 | slr |
Investments In Marketable Equity Securities At Fair Value
InvestmentsInMarketableEquitySecuritiesAtFairValue
|
1278000 | usd |
CY2022Q4 | slr |
Investments In Marketable Equity Securities At Fair Value
InvestmentsInMarketableEquitySecuritiesAtFairValue
|
949000 | usd |
CY2022Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
38000 | usd |
CY2022Q4 | us-gaap |
Assets Current
AssetsCurrent
|
5254000 | usd |
CY2022Q4 | us-gaap |
Mineral Properties Net
MineralPropertiesNet
|
16646000 | usd |
CY2022Q4 | us-gaap |
Other Assets
OtherAssets
|
134000 | usd |
CY2023Q1 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0000917225 | |
CY2023Q1 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2023Q1 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2023Q1 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
CY2023Q1 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2023 | |
CY2022Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
CY2022Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2023Q1 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2023Q1 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
64801373 | shares |
CY2023Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
64801373 | shares |
CY2023Q1 | dei |
Document Type
DocumentType
|
10-Q | |
CY2023Q1 | dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | |
CY2023Q1 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2023-03-31 | |
CY2023Q1 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2023Q1 | dei |
Entity File Number
EntityFileNumber
|
001-39278 | |
CY2023Q1 | dei |
Entity Registrant Name
EntityRegistrantName
|
SOLITARIO ZINC CORP. | |
CY2023Q1 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
CO | |
CY2023Q1 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
84-1285791 | |
CY2023Q1 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
4251 Kipling St. Suite 390 | |
CY2023Q1 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Wheat Ridge | |
CY2023Q1 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
CO | |
CY2023Q1 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
80033 | |
CY2023Q1 | dei |
City Area Code
CityAreaCode
|
303 | |
CY2023Q1 | dei |
Local Phone Number
LocalPhoneNumber
|
534-1030 | |
CY2023Q1 | dei |
Security12b Title
Security12bTitle
|
Common Stock, $0.01 par value | |
CY2023Q1 | dei |
Trading Symbol
TradingSymbol
|
XPL | |
CY2023Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2023Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
CY2023Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
21671000 | usd |
CY2023Q1 | us-gaap |
Exploration Expense
ExplorationExpense
|
275000 | usd |
CY2023Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
6000 | usd |
CY2022Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
8000 | usd |
CY2023Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
476000 | usd |
CY2022Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
387000 | usd |
CY2022Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
621000 | usd |
CY2022Q1 | us-gaap |
Other Interest And Dividend Income
OtherInterestAndDividendIncome
|
27000 | usd |
CY2022Q1 | us-gaap |
Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
|
-1000 | usd |
CY2022Q1 | us-gaap |
Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
|
-81000 | usd |
CY2023Q1 | us-gaap |
Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
|
21000 | usd |
CY2023Q1 | us-gaap |
Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
|
329000 | usd |
CY2023Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
377000 | usd |
CY2022Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
107000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-380000 | usd |
CY2023Q1 | slr |
Earnings Loss Per Share Basic And Diluted
EarningsLossPerShareBasicAndDiluted
|
-0.01 | |
CY2022Q1 | slr |
Earnings Loss Per Share Basic And Diluted
EarningsLossPerShareBasicAndDiluted
|
-0.01 | |
CY2023Q1 | slr |
Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
|
64801 | shares |
CY2022Q1 | slr |
Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
|
62728 | shares |
CY2023Q1 | us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
10000 | usd |
CY2022Q1 | us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
10000 | usd |
CY2023Q1 | slr |
Unrealized Gain Loss On Short Term Investments
UnrealizedGainLossOnShortTermInvestments
|
-21000 | usd |
CY2022Q1 | slr |
Unrealized Gain Loss On Short Term Investments
UnrealizedGainLossOnShortTermInvestments
|
51000 | usd |
CY2022Q1 | us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
13000 | usd |
CY2022Q1 | slr |
Loss On Sale Of Marketable Equity Securities
LossOnSaleOfMarketableEquitySecurities
|
81000 | usd |
CY2022Q1 | us-gaap |
Gain Loss On Derivative Instruments Held For Trading Purposes Net
GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet
|
1000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
12000 | usd |
CY2022Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-14000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-50000 | usd |
CY2022Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-20000 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-685000 | usd |
CY2022Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-597000 | usd |
CY2023Q1 | slr |
Purchase Sale Of Short Term Investments Net
PurchaseSaleOfShortTermInvestmentsNet
|
809000 | usd |
CY2022Q1 | slr |
Purchase Sale Of Short Term Investments Net
PurchaseSaleOfShortTermInvestmentsNet
|
-1578000 | usd |
CY2022Q1 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
26000 | usd |
CY2022Q1 | us-gaap |
Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
|
10000 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
809000 | usd |
CY2022Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-1562000 | usd |
CY2022Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
2023000 | usd |
CY2022Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
19000 | usd |
CY2022Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
2042000 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
124000 | usd |
CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-117000 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
316000 | usd |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
462000 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
440000 | usd |
CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
345000 | usd |
CY2023Q1 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in;text-indent:0.5in">Solitario faces risks related to health epidemics and other outbreaks of communicable diseases, which could significantly disrupt its operations and may materially and adversely affect its business and financial condition.</p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in;text-indent:0.5in">Solitario’s business still could be adversely impacted by the effects of the coronavirus (“COVID-19”) or other epidemics or pandemics. Solitario continues to evaluate the effects of COVID-19 on its operations and at times during the pandemic has taken pro-active steps to address the impacts on its operations, including reducing costs, in response to the economic uncertainty associated with potential risks from COVID-19. These prior cost reductions included implementing salary reductions and evaluating and reducing certain planned exploration programs through its joint venture partners at the Florida Canyon and Lik exploration projects. Certain of Solitario’s joint venture partners have, from time to time, modified plans with respect to the projects in which Solitario holds an interest in response to the COVID-19 pandemic. Also, Solitairo has evaluated the potential impacts on its ability to access future traditional funding sources on the same or reasonably similar terms as in past periods. Solitario will continue to monitor the effects of COVID-19 on its operations, financial condition, and liquidity. However, the extent to which COVID-19 or other epidemics or pandemics ultimately impact Solitario’s business, including its exploration and other activities and the market for its securities, will depend on future developments, which are highly uncertain and cannot be predicted at this time, and include the duration, severity and scope of any new outbreak and the actions taken to contain or treat the COVID-19 pandemic or other epidemics or pandemics.</p> | |
CY2023Q1 | slr |
Cash And Cash Equivalents Held In Brokerage Accounts And Foreign Banks
CashAndCashEquivalentsHeldInBrokerageAccountsAndForeignBanks
|
425000 | usd |
CY2023Q1 | us-gaap |
Us Government Securities At Carrying Value
USGovernmentSecuritiesAtCarryingValue
|
3163000 | usd |
CY2023Q1 | slr |
Maturities Period Of Current Assets In United States Treasury Securities
MaturitiesPeriodOfCurrentAssetsInUnitedStatesTreasurySecurities
|
30 days to 11 months | |
CY2023Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
5390000 | shares |
CY2022Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
5440000 | shares |
CY2023Q1 | us-gaap |
Mineral Properties Net
MineralPropertiesNet
|
16646000 | usd |
CY2022Q4 | us-gaap |
Mineral Properties Net
MineralPropertiesNet
|
16646000 | usd |
CY2023Q1 | us-gaap |
Exploration Expense
ExplorationExpense
|
275000 | usd |
CY2022Q1 | us-gaap |
Exploration Expense
ExplorationExpense
|
226000 | usd |
CY2023Q1 | slr |
Investments In Marketable Equity Securities At Fair Value
InvestmentsInMarketableEquitySecuritiesAtFairValue
|
1278000 | usd |
CY2022Q4 | slr |
Investments In Marketable Equity Securities At Fair Value
InvestmentsInMarketableEquitySecuritiesAtFairValue
|
949000 | usd |
CY2023Q1 | us-gaap |
Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
|
1440000 | usd |
CY2022Q4 | us-gaap |
Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
|
1440000 | usd |
CY2023Q1 | slr |
Unrealized Gain Loss On Marketable Equity Securities
UnrealizedGainLossOnMarketableEquitySecurities
|
-162000 | usd |
CY2022Q4 | slr |
Unrealized Gain Loss On Marketable Equity Securities
UnrealizedGainLossOnMarketableEquitySecurities
|
-491000 | usd |
CY2023Q1 | slr |
Investments In Marketable Equity Securities At Fair Value
InvestmentsInMarketableEquitySecuritiesAtFairValue
|
1278000 | usd |
CY2022Q4 | slr |
Investments In Marketable Equity Securities At Fair Value
InvestmentsInMarketableEquitySecuritiesAtFairValue
|
949000 | usd |
CY2023Q1 | slr |
Cost Of Marketable Equity Securities Sold
CostOfMarketableEquitySecuritiesSold
|
0 | usd |
CY2022Q1 | slr |
Cost Of Marketable Equity Securities Sold
CostOfMarketableEquitySecuritiesSold
|
107000 | usd |
CY2023Q1 | slr |
Realized Gain On Marketable Equity Securities Sold
RealizedGainOnMarketableEquitySecuritiesSold
|
0 | usd |
CY2022Q1 | slr |
Realized Gain On Marketable Equity Securities Sold
RealizedGainOnMarketableEquitySecuritiesSold
|
-81000 | usd |
CY2023Q1 | us-gaap |
Proceeds From Sale Of Equity Securities Fv Ni
ProceedsFromSaleOfEquitySecuritiesFvNi
|
0 | usd |
CY2022Q1 | us-gaap |
Proceeds From Sale Of Equity Securities Fv Ni
ProceedsFromSaleOfEquitySecuritiesFvNi
|
26000 | usd |
CY2023Q1 | slr |
Net Gain Losses On Marketable Securities
NetGainLossesOnMarketableSecurities
|
329000 | usd |
CY2022Q1 | slr |
Net Gain Losses On Marketable Securities
NetGainLossesOnMarketableSecurities
|
132000 | usd |
CY2022Q1 | us-gaap |
Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments
|
106000 | usd |
CY2023Q1 | slr |
Net Gain Losses On Marketable Securities
NetGainLossesOnMarketableSecurities
|
329000 | usd |
CY2022Q1 | us-gaap |
Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
|
213000 | usd |
CY2023Q1 | slr |
Realized Gain On Marketable Equity Securities Sold
RealizedGainOnMarketableEquitySecuritiesSold
|
0 | usd |
CY2022Q1 | slr |
Realized Gain On Marketable Equity Securities Sold
RealizedGainOnMarketableEquitySecuritiesSold
|
-81000 | usd |
CY2023Q1 | us-gaap |
Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
|
329000 | usd |
CY2022Q1 | slr |
Net Gain Losses On Marketable Securities
NetGainLossesOnMarketableSecurities
|
132000 | usd |
CY2023Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
25000 | usd |
CY2023Q1 | us-gaap |
Interest Portion Of Minimum Lease Payments Sale Leaseback Transactions
InterestPortionOfMinimumLeasePaymentsSaleLeasebackTransactions
|
0 | usd |
CY2023Q1 | slr |
Present Value Of Leases Payments
PresentValueOfLeasesPayments
|
25000 | usd |
CY2023Q1 | us-gaap |
Operating Lease Payments Use
OperatingLeasePaymentsUse
|
11000 | usd |
CY2022Q1 | us-gaap |
Operating Lease Payments Use
OperatingLeasePaymentsUse
|
11000 | usd |
CY2023Q1 | us-gaap |
Other Assets
OtherAssets
|
118000 | usd |
CY2022Q4 | us-gaap |
Other Assets
OtherAssets
|
134000 | usd |
CY2023Q1 | us-gaap |
Short Term Investments
ShortTermInvestments
|
3163000 | usd |
CY2023Q1 | slr |
Investments In Marketable Equity Securities At Fair Value
InvestmentsInMarketableEquitySecuritiesAtFairValue
|
1278000 | usd |
CY2022Q4 | us-gaap |
Short Term Investments
ShortTermInvestments
|
3951000 | usd |
CY2022Q4 | slr |
Investments In Marketable Equity Securities At Fair Value
InvestmentsInMarketableEquitySecuritiesAtFairValue
|
949000 | usd |
CY2023Q1 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
550000 | usd |
CY2022Q1 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P29M | |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
21646000 | usd |
CY2023Q1 | us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
67000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-380000 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
21333000 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
23183000 | usd |
CY2022Q1 | us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
13000 | usd |
CY2022Q1 | slr |
Issuance Of Shares Atm Net Value
IssuanceOfSharesAtmNetValue
|
2023000 | usd |
CY2022Q1 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
19000 | usd |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-514000 | usd |
CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
24724000 | usd |